BackNeumora Therapeutics Overview

Neumora Therapeutics Operating Income

Operating Income for NMRA.

Quarterly Operating Income

$-52864000.00
25.48% YoY

As of Mar 31, 2026

Annual Operating Income (TTM)

$-223084000.00
18.68% YoY

Trailing 12 months ending Mar 31, 2026

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)